Numab to receive first milestone payment Boehringer Ingelheim has advanced its novel tumor antigen targeting T cell engager resulting from a collaboration with Numab into preclinical development ...
Late-breaking clinical data presented at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis Across non-active progressive MS (primary progressive and ...
CITIZENS DEFENDS AGAINST CRITICISM — The state’s insurer of last resort is trying to push back against a rising chorus of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback